Bioceptive, Inc. is a New Orleans, LA-based medical device company focused on women's health. The company is led by Stewart B. Davis, MD (CEO and President), Shuchi “SK” Khurana (COO), and Benjamin D. Cappiello (CSO). Bioceptive has developed a novel IUD inserter designed to enhance the safety and efficacy of insertion procedures globally. The inserter launched in 2010 and is currently in a late development phase with preclinical testing underway. In April 2013 the company received $1.1M in funding to support its development efforts. As part of the financing, Orin Levy, MD, MBA, a New World Angels director, joined Bioceptive’s board of directors. Bioceptive is developing a patent‑pending device intended to simplify intrauterine device (IUD) insertion for physicians and make the procedure more comfortable for women. The company says the device targets adverse effects tied to current insertion methods, including infection, pain and IUD expulsion. The article notes IUD expulsion occurs in roughly 2–10% of users and is correlated with the experience of the medical provider inserting the device. Bioceptive plans to finalize the device, test it in cadavers and begin the FDA clearance process within the next six months. The company was formed in 2010 by Shuchi Khurana and Ben Capiello and is housed at the New Orleans BioInnovation Center. Bioceptive is raising $250,000 to complete development and regulatory work; Gray Ghost Ventures in Atlanta is the only known investor. The piece frames the opportunity against broader contraceptive market context cited in the article (a $15.5 billion global market cited, with a 2017 projection to surpass $19 billion).

Total raised

$1M

Funding rounds

2

Latest round

Equity

Latest activity

Apr 2013